Company Filing History:
2 out of 5 
1 out of 511 
1 out of 2 Years Active: 1994-1997
Title: The Innovations of Steven J Projan
Introduction
Steven J Projan is a notable inventor based in New York, NY (US). He has made significant contributions to the field of microbiology, particularly in the development of compounds that combat antibiotic resistance. With a total of 4 patents, Projan's work has had a profound impact on the treatment of bacterial infections.
Latest Patents
One of Projan's latest patents focuses on the inhibition of expression of beta-lactamase using esters of fatty acid. This class of chemical compounds comprises fatty acid ester derivatives that are used to inhibit beta-lactamase production by infectious bacteria. These inhibitors have been found to retard the resistance of certain strains of bacteria to beta-lactam antibiotics, such as penicillin. By interfering with the transcription of the beta-lactamase gene, these compounds preclude the expression of beta-lactamase. Consequently, they permit effective treatment of infections caused by otherwise resistant bacteria with antibiotics.
Career Highlights
Throughout his career, Projan has worked with various organizations, including Applied Microbiology, Inc. and Johnson & Johnson GmbH. His expertise in microbiology and innovative approaches to antibiotic resistance have positioned him as a key figure in the field.
Collaborations
Projan has collaborated with notable individuals such as Peter Blackburn and Edward B Goldberg. These partnerships have further enhanced his research and development efforts in combating bacterial resistance.
Conclusion
Steven J Projan's contributions to microbiology and antibiotic resistance are invaluable. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes.